Biochemical markers of bone remodeling

被引:22
作者
Kleerekoper, M [1 ]
机构
[1] WAYNE STATE UNIV,SCH MED,DEPT INTERNAL MED,DETROIT,MI 48201
关键词
osteoporosis; biochemical marks; bone remodeling; bone resorption; bone formation;
D O I
10.1097/00000441-199612000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone formation and resorption (or bone turnover) are reflected by levels in blood and urine of various enzymes from bone cells, byproducts of bone matrix synthesis, or breakdown products of bone. These biochemical markers provide information about projected rates of bone loss and can be useful in assessing the effectiveness of antiresorptive therapy for osteoporosis. Biochemical markers provide adjunctive information to bone density measurements, and may be independent predictors of fracture risk. For clinical use, combining markers of resorption and formation should give better information than a single marker.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 35 条
[1]  
BELL N, 1996, J BONE MINER RES S1, V11, pS156
[2]   Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis [J].
Bettica, P ;
Taylor, AK ;
Talbot, J ;
Moro, L ;
Talamini, R ;
Baylink, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02) :542-546
[3]  
BONDE M, 1994, CLIN CHEM, V40, P2022
[4]   BONE TURNOVER IN POSTMENOPAUSAL OSTEOPOROSIS - EFFECT OF CALCITONIN TREATMENT [J].
CIVITELLI, R ;
GONNELLI, S ;
ZACCHEI, F ;
BIGAZZI, S ;
VATTIMO, A ;
AVIOLI, LV ;
GENNARI, C .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) :1268-1274
[5]   BONE GLA PROTEIN (OSTEOCALCIN) ASSAY STANDARDIZATION REPORT [J].
DELMAS, PD ;
CHRISTIANSEN, C ;
MANN, KG ;
PRICE, PA .
JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (01) :5-11
[6]   Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis [J].
Devogelaer, JP ;
Broll, H ;
CorreaRotter, R ;
Cumming, DC ;
DeDeuxchaisnes, CN ;
Geusens, P ;
Hosking, D ;
Jaeger, P ;
Kaufman, JM ;
Leite, M ;
Leon, J ;
Liberman, U ;
Menkes, CJ ;
Meunier, PJ ;
Reid, I ;
Rodriguez, J ;
Romanowicz, A ;
Seeman, E ;
Vermeulen, A ;
Hirsch, LJ ;
Lombardi, A ;
Plezia, K ;
Santora, AC ;
Yates, AJ ;
Yuan, W .
BONE, 1996, 18 (02) :141-150
[7]  
EYRE D, 1987, METHOD ENZYMOL, V144, P115
[8]  
FARLEY JR, 1981, CLIN CHEM, V27, P2002
[9]  
Frost H. M., 1973, BONE REMODELING ITS
[10]   COMPARISON OF NEW BIOCHEMICAL MARKERS OF BONE TURNOVER IN LATE POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN RESPONSE TO ALENDRONATE TREATMENT [J].
GARNERO, P ;
SHIH, WCJ ;
GINEYTS, E ;
KARPF, DB ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1693-1700